These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32697945)

  • 1. A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer.
    Sharma MB; Jensen K; Urbak SF; Funding M; Johansen J; Bechtold D; Amidi A; Eskildsen SF; Jørgensen JOL; Grau C
    Radiother Oncol; 2020 Oct; 151():58-65. PubMed ID: 32697945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
    Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.
    Batth SS; Sreeraman R; Dienes E; Beckett LA; Daly ME; Cui J; Mathai M; Purdy JA; Chen AM
    Br J Radiol; 2013 Dec; 86(1032):20130459. PubMed ID: 24167183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
    Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
    Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation.
    Al-Mamgani A; Monserez D; Rooij Pv; Verduijn GM; Hardillo JA; Levendag PC
    Oral Oncol; 2012 Sep; 48(9):905-11. PubMed ID: 22584070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
    Madani I; Bonte K; Vakaet L; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):424-32. PubMed ID: 18755554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.
    Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Münter MW
    Radiat Oncol; 2011 Apr; 6():30. PubMed ID: 21466696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Genitourinary Toxicity Outcomes in 300 Prostate Cancer Patients Treated With Dose-escalated Image-guided Intensity-modulated Radiotherapy.
    Byrne K; Hruby G; Kneebone A; Whalley D; Guo L; McCloud P; Eade T
    Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):617-625. PubMed ID: 28416260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking.
    Ghadjar P; Vock J; Vetterli D; Manser P; Bigler R; Tille J; Madlung A; Behrensmeier F; Mini R; Aebersold DM
    Radiat Oncol; 2008 Oct; 3():35. PubMed ID: 18937833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
    White EC; Murphy JD; Chang DT; Koong AC
    Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.